# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001654954-21-010321
Filing Date
2021-09-23
Accepted
2021-09-23 09:51:26
Documents
50
Period of Report
2021-09-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | gtbp_8k.htm iXBRL | 8-K | 19530
2 | DR. JEFFREY MILLER PRESENTATION | gtbp_ex991.htm | EX-99.1 | 6882
3 | GT BIOPHARMA, INC. CORPORATE PRESENTATION | gtbp_ex992.htm | EX-99.2 | 15443
4 | IMAGE | gtbp_ex991img1.jpg | GRAPHIC | 102918
5 | IMAGE | gtbp_ex991img10.jpg | GRAPHIC | 75003
6 | IMAGE | gtbp_ex991img2.jpg | GRAPHIC | 57806
7 | IMAGE | gtbp_ex991img3.jpg | GRAPHIC | 77642
8 | IMAGE | gtbp_ex991img4.jpg | GRAPHIC | 96473
9 | IMAGE | gtbp_ex991img5.jpg | GRAPHIC | 76357
10 | IMAGE | gtbp_ex991img6.jpg | GRAPHIC | 54383
11 | IMAGE | gtbp_ex991img7.jpg | GRAPHIC | 78120
12 | IMAGE | gtbp_ex991img8.jpg | GRAPHIC | 94773
13 | IMAGE | gtbp_ex991img9.jpg | GRAPHIC | 91686
14 | IMAGE | gtbp_ex992img1.jpg | GRAPHIC | 26914
15 | IMAGE | gtbp_ex992img10.jpg | GRAPHIC | 109194
16 | IMAGE | gtbp_ex992img11.jpg | GRAPHIC | 60897
17 | IMAGE | gtbp_ex992img12.jpg | GRAPHIC | 73841
18 | IMAGE | gtbp_ex992img13.jpg | GRAPHIC | 50267
19 | IMAGE | gtbp_ex992img14.jpg | GRAPHIC | 60121
20 | IMAGE | gtbp_ex992img15.jpg | GRAPHIC | 81345
21 | IMAGE | gtbp_ex992img16.jpg | GRAPHIC | 78921
22 | IMAGE | gtbp_ex992img17.jpg | GRAPHIC | 53315
23 | IMAGE | gtbp_ex992img18.jpg | GRAPHIC | 45496
24 | IMAGE | gtbp_ex992img19.jpg | GRAPHIC | 64470
25 | IMAGE | gtbp_ex992img2.jpg | GRAPHIC | 151953
26 | IMAGE | gtbp_ex992img20.jpg | GRAPHIC | 79141
27 | IMAGE | gtbp_ex992img21.jpg | GRAPHIC | 75028
28 | IMAGE | gtbp_ex992img22.jpg | GRAPHIC | 78826
29 | IMAGE | gtbp_ex992img23.jpg | GRAPHIC | 56162
30 | IMAGE | gtbp_ex992img24.jpg | GRAPHIC | 26967
31 | IMAGE | gtbp_ex992img3.jpg | GRAPHIC | 48110
32 | IMAGE | gtbp_ex992img4.jpg | GRAPHIC | 115744
33 | IMAGE | gtbp_ex992img5.jpg | GRAPHIC | 60022
34 | IMAGE | gtbp_ex992img6.jpg | GRAPHIC | 63579
35 | IMAGE | gtbp_ex992img7.jpg | GRAPHIC | 70060
36 | IMAGE | gtbp_ex992img8.jpg | GRAPHIC | 71328
37 | IMAGE | gtbp_ex992img9.jpg | GRAPHIC | 69418
| Complete submission text file | 0001654954-21-010321.txt |  | 3581759

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
38 | XBRL TAXONOMY EXTENSION SCHEMA | gtpb-20210917.xsd | EX-101.SCH | 5595
39 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | gtpb-20210917_cal.xml | EX-101.CAL | 890
40 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | gtpb-20210917_def.xml | EX-101.DEF | 2097
41 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | gtpb-20210917_lab.xml | EX-101.LAB | 14803
42 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | gtpb-20210917_pre.xml | EX-101.PRE | 9411
43 | EXTRACTED XBRL INSTANCE DOCUMENT | gtbp_8k_htm.xml | XML | 3598

Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40023 | Film No.: 211271284
SIC: 2834 Pharmaceutical Preparations